| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
47,114 |
45,951 |
$3.20M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,240 |
28,117 |
$2.78M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,890 |
6,845 |
$670K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,387 |
8,331 |
$135K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,333 |
2,451 |
$78K |
| 36415 |
Collection of venous blood by venipuncture |
8,344 |
8,104 |
$38K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
375 |
374 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
238 |
237 |
$34K |
| 99173 |
|
768 |
765 |
$29K |
| 99051 |
|
892 |
864 |
$29K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,601 |
1,480 |
$28K |
| 81003 |
|
12,141 |
11,916 |
$26K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
237 |
236 |
$24K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
124 |
123 |
$12K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,014 |
997 |
$11K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
107 |
106 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
149 |
148 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
223 |
223 |
$8K |
| 81025 |
|
788 |
778 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
39 |
39 |
$4K |
| 87807 |
|
162 |
160 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
228 |
226 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
80 |
78 |
$2K |
| 93000 |
|
115 |
110 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13 |
13 |
$1K |
| A7015 |
Aerosol mask, used with dme nebulizer |
724 |
715 |
$1K |
| 82947 |
|
299 |
289 |
$1K |
| 82043 |
|
192 |
190 |
$982.54 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
21 |
20 |
$784.02 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
22 |
22 |
$560.69 |
| 98968 |
|
13 |
12 |
$368.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
87 |
81 |
$178.95 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
366 |
361 |
$164.91 |
| 96127 |
|
14 |
13 |
$126.75 |
| 85018 |
|
57 |
56 |
$123.23 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
510 |
502 |
$70.25 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
14 |
14 |
$54.19 |
| 82962 |
|
12 |
12 |
$31.76 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
86 |
85 |
$3.62 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
13 |
13 |
$0.64 |
| 3210F |
|
138 |
138 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
296 |
273 |
$0.00 |
| 3725F |
|
13 |
13 |
$0.00 |
| 3077F |
|
12 |
12 |
$0.00 |
| 4120F |
|
12 |
12 |
$0.00 |
| 4013F |
|
13 |
12 |
$0.00 |
| 3008F |
|
985 |
923 |
$0.00 |
| 1220F |
|
844 |
829 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
125 |
124 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
84 |
83 |
$0.00 |